Market simply looking for confirmation of the ongoing mid teens annual profit growth into the medium term for share price to reach new highs. Any quickening of margin (re)expansion will supercharge rerating.
- Forums
- ASX - By Stock
- CSL
- CSL - $300 and beyond
CSL - $300 and beyond, page-102
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$294.55 |
Change
-14.385(4.66%) |
Mkt cap ! $142.7B |
Open | High | Low | Value | Volume |
$300.03 | $301.28 | $291.47 | $280.8M | 944.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 98 | $294.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$294.57 | 20 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 116 | 294.440 |
5 | 39 | 294.430 |
1 | 25 | 294.420 |
4 | 42 | 294.410 |
3 | 43 | 294.400 |
Price($) | Vol. | No. |
---|---|---|
294.470 | 123 | 5 |
294.490 | 61 | 1 |
294.510 | 35 | 1 |
294.520 | 31 | 3 |
294.550 | 6 | 1 |
Last trade - 14.54pm 13/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online